[ad_1]
Bologna, March 30, 2021 – “We needed and need many more doses,” he reiterated yesterday Stefano bonaccini after the meeting between the Government and the Regions. The president of Emilia Romagna will soon be satisfied. The Regions appreciate the confirmation of the size of the next deliveries: 50 million doses in the second quarter, 80 million in the third quarter, along with the fact that Johnson & Johnson Single Dose Vaccine, whose official name is Janssen Covid-19 Vaccine. When? As of April 16 in Italy, as leaked from sources close to the emergency commissioner, Figliuolo.
Johnson & Johnson vaccine efficacy
“The Efficacy of the Janssen Covid-19 Vaccine (Johnson & Johnson) Single Dose Vaccine, in Severe Ways, Comes up to 77% after 14 days of the administration and85% after 28 days from the administration ”, reads the portal of the Ministry of Health.
How the vaccine works: how many doses are needed for immunity
This is a highly anticipated new entry, also because prophylaxis is single dose, unlike those that are currently used and that require to be withdrawn. The Johnson & Johnson vaccine, in fact, is the first of which the WHO has given the green light to request an injection instead of two, in addition to being able to be kept at refrigerator temperature. The pharmaceutical group has also agreed to sell it to cost price.
This vaccine was, in mid-March, the fourth to receive the green light from the European Medicines Agency (Mother), after those of Pfizer-BioNTech, Moderna and AstraZeneca. And it was also approved byAifa (Italian Medicines Agency). Currently it is only administered in USA and in South Africa, but it was also approved in Canada.
On March 1, the vaccine received the green light in the United States, where the FDA (Food and Drug Administration) had confirmed “the safety and efficacy of the single dose of serum against Johnson’s Coronavirus & Johnson, in particular against severe cases “. In addition, already last July, a study published in Nature revealed that this vaccine, based on vectors derived from adenovirus serotype 26 (Ad26), had induced a “strong immune response” in primates. as tested by neutralizing antibodies.
Where it occurs
To increase production and meet demand, Johnson & Johnson has adjusted several agreements in recent months with laboratories and subcontractors in Europe, who will be responsible for its formulation or bottling: these are Sanofi in France, Catalent in Italy and IDT Biologika in Germany. The active ingredient will come from the Johnson & Johnson site in Leiden, the Netherlands.
The EU, which has ordered 200 million doses from the US laboratory (with an option for an additional 200 million doses), is expected to receive around 55 million doses in the second quarter, President Ursula von der Leyen explained midway through. of March. . of the European Commission. All ‘ItalyAccording to the European agreements, the 7.3 million doses in the second quarter and 15.9 in the third.
Covid vaccine, the latest news
Traveling abroad: new rules for those returning from EU countries
Covid: Dragons vaccinated with AstraZeneca
Covid, how long does the immunity of those vaccinated last? Guido Rasi’s prediction
© All rights reserved
